Roth MKM analyst Jason Wittes raised the firm’s price target on Monogram Orthopaedics (MGRM) to $5.40 from $4 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGRM:
- Monogram Orthopaedics Gains FDA Clearance for TKA System
- Monogram Orthopaedics announces 510(k) clearance for mBos TKA System
- Monogram Orthopaedics Earnings Call: Balancing Innovation and Regulatory Challenges
- Monogram Technologies Advances in Orthopedic Robotics
- MGRM Earnings this Week: How Will it Perform?